Literature DB >> 11807233

Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5' sequence: evidence from a plasmid-driven system.

S D Duhaut1, N J Dimmock1.   

Abstract

The presence of at least 80-90 and more typically around 200 nucleotides (nt) at the 5' end of the virion-sense RNA in all naturally occurring defective influenza A virus RNAs suggests that this is essential sequence, whereas the 3'-end sequence may be as short as 25 nt. The stability of defective RNA on serial passage with infectious helper virus also depends on the length of 5'-end sequence. Here, we have studied the influence of 5'-end sequences of a panel of six defective segment 1 RNAs from H3N8 and H7N7 viruses on their ability to interfere with the multiplication of plasmid-produced infectious A/WSN virus (H1N1). Four of the H3N8 defective RNAs are identical in overall length but vary in the length of 5' sequence. Transfected defective RNAs interfered with infectious virus production in a concentration-dependent manner. The extent of interference also depended on the length of 5'-end sequence in the defective genome. This required at least 150 nt and was maximal with 220 nt of 5' end sequence. The reduction in virus multiplication was highly significant and correlated with the presence of detectable intracellular defective RNA. Packaging of full-length segment 1 RNA by progeny virus was inversely proportional to the packaging of defective segment 1 RNA and may explain the reduction in infectivity. In summary, a critical length of 5'-end sequence is essential for the interfering properties of defective influenza virus RNAs, which indicates that this plays some vital role in the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807233     DOI: 10.1099/0022-1317-83-2-403

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

Review 2.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

3.  Emergence of the virulence-associated PB2 E627K substitution in a fatal human case of highly pathogenic avian influenza virus A(H7N7) infection as determined by Illumina ultra-deep sequencing.

Authors:  Marcel Jonges; Matthijs R A Welkers; Rienk E Jeeninga; Adam Meijer; Peter Schneeberger; Ron A M Fouchier; Menno D de Jong; Marion Koopmans
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 4.  The biology of influenza viruses.

Authors:  Nicole M Bouvier; Peter Palese
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

5.  Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging.

Authors:  Glenn A Marsh; Raúl Rabadán; Arnold J Levine; Peter Palese
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

6.  A functional sequence-specific interaction between influenza A virus genomic RNA segments.

Authors:  Cyrille Gavazzi; Matthieu Yver; Catherine Isel; Redmond P Smyth; Manuel Rosa-Calatrava; Bruno Lina; Vincent Moulès; Roland Marquet
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-25       Impact factor: 11.205

Review 7.  Implications of segment mismatch for influenza A virus evolution.

Authors:  Maria C White; Anice C Lowen
Journal:  J Gen Virol       Date:  2017-12-15       Impact factor: 3.891

Review 8.  Defective Interfering Particles of Negative-Strand RNA Viruses.

Authors:  Christopher M Ziegler; Jason W Botten
Journal:  Trends Microbiol       Date:  2020-03-26       Impact factor: 17.079

9.  An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus.

Authors:  Cyrille Gavazzi; Catherine Isel; Emilie Fournier; Vincent Moules; Annie Cavalier; Daniel Thomas; Bruno Lina; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2012-12-05       Impact factor: 16.971

10.  Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir.

Authors:  Nigel J Dimmock; Brian K Dove; Bo Meng; Paul D Scott; Irene Taylor; Linda Cheung; Bassam Hallis; Anthony C Marriott; Miles W Carroll; Andrew J Easton
Journal:  Antiviral Res       Date:  2012-10-04       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.